STERIS plc
NYSE:STE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
STERIS plc
NYSE:STE
|
IE |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
Acousort AB
F:4SA
|
SE |
|
S
|
Schloss Wachenheim AG
DUS:SWA
|
DE |
|
P
|
PureTech Health PLC
NASDAQ:PRTC
|
US |
|
G
|
GE Vernova LLC
NYSE:GEV
|
US |
Wall St Price Targets
STE Price Targets Summary
STERIS plc
According to Wall Street analysts, the average 1-year price target for STE is 269.947 USD with a low forecast of 227.25 USD and a high forecast of 309.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STE's stock price target?
Price Target
269.947
USD
According to Wall Street analysts, the average 1-year price target for STE is 269.947 USD with a low forecast of 227.25 USD and a high forecast of 309.75 USD.
What is the Revenue forecast for STERIS plc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for STERIS plc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for STERIS plc?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 18%.
What is the Pre-Tax Income forecast for STERIS plc?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for STERIS plc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 5 years is 13%.
